Sophia Randolph, Chief Medical Officer at ALX ONCOLOGY HOLDINGS INC (ALXO), sold 1,617 shares at $11.07 ($18K) on 2022-12-29, disclosed to the SEC on 2023-01-03.
Open-market sale of $18k ALXO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALXO | SELL | 2024-05-15 | $353K | — | Filing → |
| ALXO | SELL | 2024-01-03 | $47K | — | Filing → |
| ALXO | SELL | 2023-07-05 | $12K | — | Filing → |